Severity of anemia during interferon and ribavirin therapy in patients with chronic active hepatitis c genotype-3 and its association with risk factors
JLUMHS-Journal of the Liaquat University of Medical Health Sciences. 2013; 12 (3): 161-166
em Inglês
| IMEMR
| ID: emr-192194
ABSTRACT
Hepatitis C is a major public health problem globally. It is one of the commonest cause of chronic liver disease in Pakistan. The prevalent genotype is "3" in our country. The standard of care treatment is combination of interferon and ribavirin. This combination has important adverse effects especially hemolytic anemia
Buscar no Google
Índice:
IMEMR (Mediterrâneo Oriental)
Idioma:
Inglês
Revista:
J. Liaquat Univ. Med. Health Sci.
Ano de publicação:
2013
Similares
MEDLINE
...
LILACS
LIS